Amyotrophic lateral sclerosis (ALS), which is also called “Lou Gehrig’s Disease,” is a neurodegenerative disease that attacks nerve cells in the brain and spinal cord. These motor neurons basically control the muscles throughout the body, and their progressive degeneration eventually leads to the death of ALS patients.
In the first stages of ALS, patients begin to lose control of their muscle movements as their motor neurons die. In later stages of the disease, voluntary muscle action is affected, and patients may become totally paralyzed.
Eye tracking devices help individuals with no control, or only limited control, over their hand movements. Eye trackers follow the movement of the eyes to allow the person to navigate the web and to type on custom screens. People living with disabilities or degenerative diseases are benefiting from eye tracking technology, including patients with ALS, multiple sclerosis, brain injuries, muscular dystrophy, cerebral palsy, spinal cord injuries and more. Eye tracking devices allow users to harness the power of their eyes to communicate.
Patients with mobility-limiting diseases, such as ALS, can benefit greatly from eye tracking technology such as our Eyegaze Edge®. The Eyegaze Edge® is an eye-operated communication and control system that allows ALS patients to communicate and interact. Eyegaze Edge® users are writing books, attending school, and communicating with their loved ones – all through the power of their eyes.
More and more people are benefitting from eye tracking technology whether they are living with paralysis or debilitating diseases. Our Eyegaze Edge® is the world’s most advanced eye-driven tablet communication system. It is internationally trusted, locally loved and continues to be the device of choice by people with ALS and other diseases and disabilities. Continue to follow our social media channels and blog as the Eyegaze team celebrates ALS Awareness Month.